Asia Pacific Clinical Trial Imaging Market Size & Outlook

The clinical trial imaging market in Asia Pacific is expected to reach a projected revenue of US$ 405.1 million by 2030. A compound annual growth rate of 8.4% is expected of Asia Pacific clinical trial imaging market from 2025 to 2030.
Revenue, 2024 (US$M)
$251.2
Forecast, 2030 (US$M)
$405.1
CAGR, 2025 - 2030
8.4%
Report Coverage
Asia Pacific

Asia Pacific clinical trial imaging market highlights

  • The Asia Pacific clinical trial imaging market generated a revenue of USD 251.7 million in 2023.
  • The market is expected to grow at a CAGR of 8.5% from 2024 to 2030.
  • In terms of segment, project and data management was the largest revenue generating service in 2023.
  • System and Technology Support Services is the most lucrative service segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 251.7 million
Market revenue in 2030USD 445.1 million
Growth rate8.5% (CAGR from 2023 to 2030)
Largest segmentProject and data management
Fastest growing segmentSystem and Technology Support Services
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationClinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management
Key market players worldwideIxico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.1% of the global clinical trial imaging market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 445.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Imaging Market Scope

Clinical trial imaging market segmentation & scope
Countries
UK
UAE
Mexico
Sweden
Denmark
Norway
Australia
Kuwait

Clinical Trial Imaging Market Companies

Name Profile # Employees HQ Website

Asia Pacific clinical trial imaging market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.


Project and data management was the largest segment with a revenue share of 28.8% in 2024. Horizon Databook has segmented the Asia Pacific clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.


The clinical trial imaging market in Asia Pacific is anticipated to exhibit significant growth over the forecast period. This can be attributed to rapid growth of the population and increased R&D activity in this region. In addition, there is high need for traditional and advanced devices & therapies in Asia Pacific.

Moreover, the cost of conducting clinical trials in Asia is lower as compared to Western Europe and the U.S. For instance, the clinical trial cost in China and India is 25% to 40% less than that in Western countries. Asia Pacific has a large population and offers great opportunity to conduct clinical trials.

Asia has become a preferred outsourcing destination due to its huge treatment-naive population, faster process of recruiting patients, cost-effectiveness, developing clinical infrastructure, and highly skilled investigators, resulting in the growth of clinical trial imaging market.

Reasons to subscribe to Asia Pacific clinical trial imaging market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific clinical trial imaging market databook

  • Our clientele includes a mix of clinical trial imaging market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific clinical trial imaging market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific clinical trial imaging market size, by country, 2018-2030 (US$M)

Asia Pacific Clinical Trial Imaging Market Outlook Share, 2024 & 2030 (US$M)

Asia Pacific clinical trial imaging market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more